|
Market Closed -
NYSE
04:02:43 2026-08-26 pm EDT
|
5-day change | 1st Jan Change | ||
| 28.30 USD | -0.95% |
|
+0.21% | +13.65% |
| 04:23am | Novo Nordisk Reports China Regulators Accept Weight-Loss Drug Application | MT |
| 11:44pm | China's drug regulator accepts Novo Nordisk's application for oral Wegovy | RE |
| Market Cap | 161B 138B 130B 119B 224B 15,385B 225B 1,538B 596B 7,761B 606B 592B 25,707B | P/E 2026 * |
17.7x | P/E 2027 * | 13.9x |
|---|---|---|---|---|---|
| Enterprise Value | 209B 179B 168B 154B 290B 19,914B 291B 1,990B 771B 10,046B 784B 767B 33,274B | EV / Sales 2026 * |
3.35x | EV / Sales 2027 * | 3.41x |
| Free-Float |
59.05% | Yield 2026 * |
6.08% | Yield 2027 * | 6.13% |
Last Transcript : Pfizer Inc.
| 1 day | -0.95% | ||
| 1 week | +0.21% | ||
| Current month | +13.15% | ||
| 1 month | +15.32% | ||
| 3 months | +9.48% | ||
| 6 months | +4.43% | ||
| Current year | +13.65% |
| 1 week | 27.66 |  | 28.58 |
| 1 month | 24.55 | | 28.58 |
| Current year | 23.62 | | 28.74 |
| 1 year | 23.58 | | 28.74 |
| 3 years | 20.92 | | 36.94 |
| 5 years | 20.92 | | 61.71 |
| 10 years | 20.92 | | 61.71 |
| Manager | Title | Age | Since |
|---|---|---|---|
Albert Bourla
CEO | Chief Executive Officer | 64 | 2018-12-31 |
Cecile Guegan
DFI | Director of Finance/CFO | 55 | 2026-08-15 |
Rady Johnson
CMP | Compliance Officer | 65 | 2013-11-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Suzanne Johnson
BRD | Director/Board Member | 68 | 2007-08-31 |
Shantanu Narayen
BRD | Director/Board Member | 62 | 2013-09-26 |
Albert Bourla
CHM | Chairman | 64 | 2019-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/14/26 | Free | Chief Executive Officer | 22 | 0.0000% | ||
| 8/12/26 | Buy | Chief Executive Officer | 38,000 | 0.0007% | ||
| 8/5/26 | Sell | Controller/Auditor | -3,278 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.95% | +0.21% | +13.56% | -22.21% | 161B | |
| -3.59% | -7.10% | +61.60% | +114.83% | 1,060B | |
| -1.15% | -1.25% | +52.98% | +62.41% | 651B | |
| -1.09% | -1.15% | +26.18% | +79.22% | 465B | |
| -1.05% | -1.94% | +38.84% | +40.69% | 365B | |
| -1.25% | -0.40% | +23.40% | +39.11% | 300B | |
| -0.67% | +1.13% | +2.64% | +12.79% | 258B | |
| -0.43% | -0.46% | +52.06% | +71.75% | 238B | |
| -2.50% | +1.15% | -16.02% | -53.67% | 210B | |
| -0.46% | +0.33% | +29.05% | +92.67% | 184B | |
| Average | -1.31% | -0.11% | +28.43% | +43.76% | 389.17B | |
| Weighted average by Cap. | -1.76% | -1.87% | +38.64% | +63.80% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 62.24B 53.42B 50.14B 45.79B 86.42B 5,936B 86.84B 593B 230B 2,995B 234B 229B 9,919B | 59.84B 51.36B 48.21B 44.03B 83.09B 5,707B 83.49B 570B 221B 2,879B 225B 220B 9,537B |
| Net income | 8.9B 7.64B 7.17B 6.55B 12.36B 849B 12.42B 84.85B 32.88B 428B 33.42B 32.69B 1,418B | 11.08B 9.51B 8.93B 8.15B 15.39B 1,057B 15.46B 106B 40.94B 533B 41.6B 40.7B 1,766B |
| Net Debt | 47.48B 40.76B 38.25B 34.94B 65.94B 4,529B 66.25B 453B 175B 2,285B 178B 174B 7,567B | 42.88B 36.81B 34.55B 31.55B 59.55B 4,090B 59.83B 409B 158B 2,063B 161B 158B 6,834B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-26 | $28.30 | -0.95% | 35,069,969 |
| 26-08-25 | $28.57 | +2.15% | 31,915,704 |
| 26-08-24 | $27.97 | -0.36% | 23,845,604 |
| 26-08-21 | $28.07 | +1.01% | 37,109,565 |
| 26-08-20 | $27.79 | -1.59% | 29,297,031 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PFE Stock
Select your edition
All financial news and data tailored to specific country editions
